The inhibition of tumor HSPs by Se supplementation results in degradation of oncoproteins such as Akt, RAF-1, and VEGFR (Chan et al., 2006; Fu et al., 2016; Hazane-Puch et al., 2016; Yakubov, 2019). The gene discussed is AKT1; the disease is neoplasm.